Showing results (21-30 of 38) with videos related to
Sort By:
Pageof 4
European Journal of Gastroenterology & Hepatology|October 23, 2013
Medical resource utilization and associated costs in patients with ulcerative colitis in the UK: a chart review analysisKeith Bodger, Linnette Yen, Agota Szende, et al.BMJ Open|January 22, 2016
Referral patterns after a seizure admission in an English region: an opportunity for effective intervention? An observational study of routine hospital dataRuth Grainger, Michael Pearson, Peter Dixon, et al.BMJ Open Gastroenterology|August 19, 2025
Increased 30-day mortality associated with weekend emergency admission for alcohol-related liver disease in England: a record-linkage study using the Clinical Practice Research DatalinkKeith Bodger, William Tench, Thomas Mair, et al.Alimentary Pharmacology & Therapeutics|May 29, 2019
Nationwide improvement in outcomes of emergency admission for ulcerative colitis in England, 2005-2013Mustafa Shawihdi, Susanna Dodd, Constantinos Kallis, et al.American Journal of Physiology. Gastrointestinal and Liver Physiology|January 16, 2007
Increased gastric expression of MMP-7 in hypergastrinemia and significance for epithelial-mesenchymal signalingAndrea Varro, Susan Kenny, Elaine Hemers, et al.Gut|February 22, 2013
Variation in gastroscopy rate in English general practice and outcome for oesophagogastric cancer: retrospective analysis of Hospital Episode StatisticsMustafa Shawihdi, Elizabeth Thompson, Neil Kapoor, et al.Journal of Crohn'S & Colitis|September 14, 2023
Validation of the IBD-Control Questionnaire across different sociodemographic and clinical subgroups: secondary analysis of a nationwide electronic surveyGerum G Gebeyehu, Frederick Taylor, Liz Dobson, et al.Therapeutic Advances in Gastroenterology|June 4, 2026
The UK vedolizumab real-life experience study in inflammatory bowel disease (VEST): patient characteristics, drug persistence and patient-centred outcomesKeith Bodger, Cheryl Booker, Frederick Taylor, et al.Alimentary Pharmacology & Therapeutics|July 10, 2026
Real-World Effectiveness, Safety and Quality of Life With Ustekinumab for the Treatment of Crohn's Disease: Results of the UK Ustekinumab Real World Evidence Study (UndieS) Study GroupDavid Young, Cheryl Booker, Mark Samaan, et al.Alimentary Pharmacology & Therapeutics|May 23, 2020
Reducing variation in hospital mortality for alcohol-related liver disease in North West EnglandConstantinos Kallis, Pete Dixon, Benjamin Silberberg, et al.Pageof 4